Clinical Trial Update: The TRANQUILITY Trial: Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease [Phase 2, Phase 3]

View source ↗

Summary

The TRANQUILITY trial evaluating an Aldeyra Therapeutics investigational therapy for dry eye disease has completed Phase 2/3 with results posted on 2025-03-19.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Aldeyra Therapeutics investigational therapy (TRANQUILITY trial)

Snippet

Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Dry Eye, Dry Eye Syndromes | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-03-19